No abstract

No abstract

There were many studies evaluating the effect of picosecond (PS) lasers, but no meta‐analysis examined the effects of PS laser in the treatment of pigmentary disorders in Asians. The aim of this article was to review the before‐after effect of PS laser in Asians for the treatment of pigmentary disorders. PubMed, Embase, and Cochrane library were searched for articles published up to May 2020. The evaluations were summarized into a 4‐point scale that ranged from <25% (poor), 25%‐50% (fair), 50%‐75% (good), and 75%‐100% (excellent). Effect sizes (ESs) were calculated according to laser wavelengths and lesion types. There were two randomized controlled trials, three single‐arm trials, and three case series, with 200 patients. At 3 months after treatment, of all included patients, 3% (95%CI: 1%‐6%) were evaluated as poor or worse, 9% (95%CI: 2%‐21%) as fair, 29% (95%CI: 12%‐50%) as good, and 56% (95%CI: 28%‐83%) as excellent. The 532 and 1064, and 755 nm PS lasers had similar ESs across all four response groups. This meta‐analysis suggested that 56% of Asian patients who underwent PS laser for the treatment of pigmentary disorders were evaluated as “excellent” about the pigment clearance by a dermatologist at least 3 months after treatment.

Sarcoidosis is a systemic granulomatous disease of unknown etiology that most frequently occurs in the lungs. However, cutaneous lesions are often the primary sign. Cutaneous sarcoidosis is difficult to treat, although different therapies have been applied. We herein report a case in which cutaneous sarcoidosis was treated with pulsed-dye laser (PDL) therapy along with oral administration of acitretin and hydroxychloroquine; no topical medications were applied. All patient details are de-identified. The treatment areas gradually improved after several courses of PDL therapy. This case illustrates that PDL therapy can serve as an auxiliary treatment for cutaneous sarcoidosis.